MASTERINVEST Kapitalanlage GmbH bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, Holdings Channel reports. The firm bought 38,103 shares of the company’s stock, valued at approximately $4,896,000.
Several other institutional investors have also recently bought and sold shares of the company. Gables Capital Management Inc. acquired a new position in Merck KGaA during the 2nd quarter worth $2,095,000. Diversify Advisory Services LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at about $3,810,000. Danske Bank A S acquired a new stake in shares of Merck KGaA in the second quarter valued at about $276,535,000. Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Merck KGaA in the second quarter worth about $25,541,000. Finally, BOK Financial Private Wealth Inc. bought a new position in shares of Merck KGaA in the second quarter worth about $523,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
OTCMKTS MKGAF opened at $158.15 on Friday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a market capitalization of $20.44 billion, a PE ratio of 24.14 and a beta of 0.96. The stock has a 50-day simple moving average of $163.21 and a 200 day simple moving average of $148.95.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
